Clinical trials
Phase 3 Death, Sudden, Cardiac trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Unknown status | 3 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 8 |
| Aspirus Heart and Vascular Institute-Research and Education | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Brigham and Women's Hospital | 1 |
| Centro Medico Teknon | 1 |
| ELA Medical, Inc. | 1 |
| Gilead Sciences | 1 |
| I.M. Sechenov First Moscow State Medical University | 1 |
| Sistema d'Emergències Mèdiques | 1 |
| US Department of Veterans Affairs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Death, Sudden, Cardiac | 21 |
| Heart Diseases | 10 |
| Arrhythmias, Cardiac | 9 |
| Cardiovascular Diseases | 9 |
| Myocardial Infarction | 7 |
| Tachycardia, Ventricular | 6 |
| Heart Arrest | 5 |
| Myocardial Ischemia | 5 |
| Ventricular Fibrillation | 5 |
| Coronary Disease | 4 |
Trials
Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.